Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PRLB - US7437131094 - Common Stock

50.475 USD
-0.12 (-0.23%)
Last: 1/2/2026, 1:49:43 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRLB. PRLB was compared to 132 industry peers in the Machinery industry. No worries on liquidiy or solvency for PRLB as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PRLB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
PRLB had a positive operating cash flow in the past year.
Of the past 5 years PRLB 4 years were profitable.
In the past 5 years PRLB always reported a positive cash flow from operatings.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.96%, PRLB is in line with its industry, outperforming 42.42% of the companies in the same industry.
The Return On Equity of PRLB (2.23%) is worse than 62.12% of its industry peers.
With a Return On Invested Capital value of 2.11%, PRLB is not doing good in the industry: 67.42% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 10.27%.
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

PRLB has a Profit Margin (2.86%) which is in line with its industry peers.
PRLB's Profit Margin has declined in the last couple of years.
PRLB has a Operating Margin of 4.35%. This is in the lower half of the industry: PRLB underperforms 63.64% of its industry peers.
In the last couple of years the Operating Margin of PRLB has declined.
PRLB's Gross Margin of 44.12% is amongst the best of the industry. PRLB outperforms 83.33% of its industry peers.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRLB has less shares outstanding
Compared to 5 years ago, PRLB has less shares outstanding
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 9.27 indicates that PRLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of PRLB (9.27) is better than 91.67% of its industry peers.
PRLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 9.27
ROIC/WACC0.22
WACC9.5%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.24 indicates that PRLB has no problem at all paying its short term obligations.
PRLB's Current ratio of 3.24 is amongst the best of the industry. PRLB outperforms 80.30% of its industry peers.
PRLB has a Quick Ratio of 3.04. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB's Quick ratio of 3.04 is amongst the best of the industry. PRLB outperforms 88.64% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 3.04
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

PRLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.02%.
PRLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.19% yearly.
The Revenue has been growing slightly by 2.82% in the past year.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-7.02%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%0%
Revenue 1Y (TTM)2.82%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.76%

3.2 Future

The Earnings Per Share is expected to grow by 6.49% on average over the next years.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.30% yearly.
EPS Next Y-2.34%
EPS Next 2Y1.89%
EPS Next 3Y6.49%
EPS Next 5YN/A
Revenue Next Year5.31%
Revenue Next 2Y5.09%
Revenue Next 3Y5.3%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.75, PRLB can be considered very expensive at the moment.
62.12% of the companies in the same industry are cheaper than PRLB, based on the Price/Earnings ratio.
PRLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 29.83, PRLB can be considered very expensive at the moment.
63.64% of the companies in the same industry are cheaper than PRLB, based on the Price/Forward Earnings ratio.
PRLB's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 31.75
Fwd PE 29.83
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than the industry average as 74.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.65
EV/EBITDA 18.65
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.89%
EPS Next 3Y6.49%

0

5. Dividend

5.1 Amount

PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PROTO LABS INC

NYSE:PRLB (1/2/2026, 1:49:43 PM)

50.475

-0.12 (-0.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners93.57%
Inst Owner Change1.31%
Ins Owners1.08%
Ins Owner Change0.28%
Market Cap1.20B
Revenue(TTM)518.38M
Net Income(TTM)14.84M
Analysts78.18
Price Target57.8 (14.51%)
Short Float %2.32%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.68%
Min EPS beat(2)17.55%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)15.66%
Min EPS beat(4)10.87%
Max EPS beat(4)17.81%
EPS beat(8)8
Avg EPS beat(8)23.41%
EPS beat(12)12
Avg EPS beat(12)26.01%
EPS beat(16)15
Avg EPS beat(16)25.13%
Revenue beat(2)1
Avg Revenue beat(2)1.29%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.41%
Revenue beat(4)2
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)3.41%
Revenue beat(8)4
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)8
Avg Revenue beat(16)0.39%
PT rev (1m)0%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.37%
EPS NY rev (1m)2.23%
EPS NY rev (3m)6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 31.75
Fwd PE 29.83
P/S 2.31
P/FCF 17.65
P/OCF 15.86
P/B 1.8
P/tB 3.22
EV/EBITDA 18.65
EPS(TTM)1.59
EY3.15%
EPS(NY)1.69
Fwd EY3.35%
FCF(TTM)2.86
FCFY5.67%
OCF(TTM)3.18
OCFY6.3%
SpS21.89
BVpS28.07
TBVpS15.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.69
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROCE 3.28%
ROIC 2.11%
ROICexc 2.56%
ROICexgc 5.3%
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
FCFM 13.06%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.08%
Cap/Sales 1.47%
Interest Coverage 250
Cash Conversion 132.03%
Profit Quality 456.43%
Current Ratio 3.24
Quick Ratio 3.04
Altman-Z 9.27
F-Score6
WACC9.5%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.02%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%0%
EPS Next Y-2.34%
EPS Next 2Y1.89%
EPS Next 3Y6.49%
EPS Next 5YN/A
Revenue 1Y (TTM)2.82%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.76%
Revenue Next Year5.31%
Revenue Next 2Y5.09%
Revenue Next 3Y5.3%
Revenue Next 5YN/A
EBIT growth 1Y-24.4%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year63.4%
EBIT Next 3Y26.27%
EBIT Next 5YN/A
FCF growth 1Y32.02%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y13.3%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%

PROTO LABS INC / PRLB FAQ

Can you provide the ChartMill fundamental rating for PROTO LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to PRLB.


What is the valuation status of PROTO LABS INC (PRLB) stock?

ChartMill assigns a valuation rating of 1 / 10 to PROTO LABS INC (PRLB). This can be considered as Overvalued.


What is the profitability of PRLB stock?

PROTO LABS INC (PRLB) has a profitability rating of 3 / 10.


What is the financial health of PROTO LABS INC (PRLB) stock?

The financial health rating of PROTO LABS INC (PRLB) is 9 / 10.


Can you provide the expected EPS growth for PRLB stock?

The Earnings per Share (EPS) of PROTO LABS INC (PRLB) is expected to decline by -2.34% in the next year.